Effect of topical ketorolac and tetracaine on the need for sedative and analgesic drugs in phacoemulsificatio
Phase 3
- Conditions
- Cataract.Age-related cataract
- Registration Number
- IRCT20170716035104N4
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
All candidates of cataract surgery with phacoemulsification under local anesthesia and sedation according to the American Society of Anesthesiologists (ASA) class I and II
Exclusion Criteria
Tetracaine allergy
Ketorolac allergy
History of drug, cigarette, alcohol or benzodiazepine addiction
Pregnancy
Need for intraoperative alternation of anesthetic technique
Opting out of the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient's post-operative pain. Timepoint: At 0, 10 and 20 minutes after the patient's admission to the recovery. Method of measurement: The Visual Analogue Scale (VAS).;Midazolam doze required for sedation. Timepoint: During the surgery. Method of measurement: Measured based on milligrams using scaled syringe.;Propofol doze required for sedation. Timepoint: During the surgery. Method of measurement: Measured based on milligrams using scaled syringe.;Nausea and vomiting in patient. Timepoint: During recovery admittion. Method of measurement: The Visual Analogue Scale (VAS).;Patient's sedation score during and after the surgery. Timepoint: During the surgery and after admitting to the recovery. Method of measurement: Visual Analogue Scale (VAS).
- Secondary Outcome Measures
Name Time Method